about
Incidental findings on cardiac computed tomography in incident hemodialysis patients: the predictors of arrhythmic and cardiovascular events in end-stage renal disease (PACE) studyIncremental short daily home hemodialysis: a case series.Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD.Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) StudyIntravenous iron exposure and mortality in patients on hemodialysisDeterminants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial.Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study.Management of the hospitalized injection drug user.Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators.Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study.Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.A finger photoplethysmography waveform during the valsalva maneuver detects changes in left heart filling pressure after hemodialysisRace, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on DialysisThe effects of weight change on glomerular filtration rate.Serum β-trace protein and risk of mortality in incident hemodialysis patientsSerum and dietary potassium and risk of incident type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) study.GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.Estimating residual kidney function in dialysis patients without urine collectionNovel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.Non-traditional risk factors are important contributors to the racial disparity in diabetes risk: the atherosclerosis risk in communities study.Hand-carried ultrasound use in clinical nephrology: Case report.Hypertension in hemodialysis patients: an opinion-based update.Biomarkers of vascular calcification and mortality in patients with ESRD.Frequency of arrhythmia symptoms and acceptability of implantable cardiac monitors in Hemodialysis patientsMetabolomics Research in Chronic Kidney Disease.Polyomavirus-associated nephropathy: a comparison of 2 different strategies for immunosuppression reductionRenal Handling of β-Trace Protein: Interpreting the EvidenceMeasurement and Estimation of Residual Kidney Function in Patients on DialysisEffect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfateIn Reply to 'Plasma Clearance of Iohexol in Hemodialysis Patients Requires Prolonged Blood Sampling'Kidney Clearance of Secretory Solutes Is Associated with Progression of CKD: The CRIC StudyMapping Progress in Reducing Cardiovascular Risk with Kidney Disease: Sudden Cardiac DeathSerum Metabolites and Cardiac Death in Patients on Hemodialysis
P50
Q33605699-799D758B-B267-43E4-88C0-4509EA6782EDQ33876429-5FB2A314-71FD-4DB9-8005-A989D2C272B6Q33981523-88C048A5-98EB-44FF-98E8-0604C8D8F110Q34023357-A0AA9F21-C682-4D6C-86BF-C3F260292E9CQ34084375-5DEE7031-FA3A-4ADC-AF0E-B76078BBF907Q34455198-52DDF8A3-84C1-4728-9905-1C6FEDBC3970Q34547489-30795443-17B2-4EAD-A8C2-FAB4A5233C53Q34793142-E4047F7E-CBCE-4803-B0A8-BD697D660C43Q34950469-CC5BA449-8925-4AAB-B57E-618426B63CDFQ35566447-5A394A9A-0F04-4D68-AC2C-BD82F0445727Q35612069-EA70A982-124F-4983-8358-2AFC281F01A1Q35739189-6173538C-4DDE-434D-AA1D-2CEEF8899B69Q35745533-58D9A76E-F2A5-4A67-8F6B-29134BD0D0A3Q36037470-31738B32-596F-4CC0-820F-58BF9D3C2A14Q36197733-AB85627C-D49F-4A77-B62D-F3714BC3E6E6Q36199548-8A9E8115-6791-4081-ACA4-B80B68DEF31CQ36312807-2EAC6571-5DA5-4A7C-B505-42EB5590104BQ36414841-B9355177-9742-44BB-B8BC-C3577A3F6041Q36805490-D4A80809-0486-484E-B817-41A5EE1722B3Q37432938-A660F3FC-A81D-40B3-B344-F51655AEB7EFQ37549763-4BBD7DBA-BB1E-4925-A5CC-CBDEA0A2995FQ37605582-617D3604-C65B-4308-9F85-583891AE89A1Q37641142-654D97F2-F71D-4560-849B-0C5B6AF88144Q37682232-47ED21B3-E151-45B1-8D5D-12EA5E2C1927Q42374500-E8CFC5AE-E432-4094-916C-50B7E6631021Q64965132-EE4ECA33-7803-4FC2-8367-C28D40C1B2C8Q84801464-A5A62FCA-C83C-4545-B0C3-8FB88A4BF0D8Q85199097-499B8232-778B-47B4-9D08-6C70DC4598DCQ87941362-6448DA38-CF47-496F-BF60-4A4C48873A89Q89220124-917FF28C-929E-43E5-AFA0-058AC7B7C5FFQ89250004-6D6CD243-13BC-4BED-9AA5-80ED366A9D94Q90604273-DFD655CB-D230-4D61-84DC-CF81FAFCD488Q90965356-E64728ED-A9F2-4639-A799-E33938F3DEFAQ92952567-06C07CB4-9C20-4E7E-A12B-442E3F55D197
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tariq Shafi
@ast
Tariq Shafi
@en
Tariq Shafi
@es
Tariq Shafi
@nl
Tariq Shafi
@sl
type
label
Tariq Shafi
@ast
Tariq Shafi
@en
Tariq Shafi
@es
Tariq Shafi
@nl
Tariq Shafi
@sl
prefLabel
Tariq Shafi
@ast
Tariq Shafi
@en
Tariq Shafi
@es
Tariq Shafi
@nl
Tariq Shafi
@sl
P106
P1153
6603077662
P31
P496
0000-0002-7222-4666